| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.089 | 0.1 |